A cost utility analysis and budget impact (BI) were developed using a decision model to compare the incremental outcomes and costs of monitoring the depth of anaesthesia with BIS monitors compared with using clinical signs, electrocardiography (ECG) and other devices (standard clinical monitoring) over a five-year period. The health outcomes included are utility values associated with adverse events avoided. An NHS perspective was adopted and costs and outcomes were discounted at 3.5% a year. Sensitivity analyses explored uncertainty in the model. In the base-case, a cohort of 100,000 patients aged 15 and older undergoing surgery lasting more than 2 hours with general anaesthetic was adopted. Subgroup analysis was conducted for an elderly patient group.
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Bispectral Index (BIS) monitoring systems monitor spontaneous electroencephalography, track sedative drug effects and help guide anaesthetic administration. At least one review of clinical evidence concludes that such monitoring presents a strong opportunity for cost reduction on anaesthesia due to demonstrated potential to reduce adverse events including cases of posttraumatic stress disorder (PTSD), postoperative nausea and vomiting (PONV), postoperative cognitive dysfunction (POCD) and postoperative delirium (POD) compared with monitoring clinical signs only. It may also reduce recovery time in the post-anaesthesia care unit and use of anaesthesia. However, the costeffectiveness of monitors is uncertain.
The aim was to conduct a cost utility analysis comparing BIS to current practice and estimate the associated budget impact of introducing BIS into theatres in the UK.
Adopting BIS monitors is clinically and cost-effective and results in substantial cost savings compared with observing clinical signs plus conventional devices only. 
Background and Aim Methods

Assumptions
Absolute event rates, relative risk reduction values and utilities were obtained from peer-reviewed literature, using systematic review sources where possible. The key values adopted are shown in Table 1 .
The modelled results show that using BIS monitors dominates clinical observation of signs and ECH being cost saving by £82 per operation, whilst improving quality adjusted life years (QALYs) by 0.016 per patient. The savings and improved QALYS arise because of the fewer adverse events.
In the population aged over 65 years, incremental savings increase to £109 because POD events are also avoided in this group. The incremental QALY of 0.016 is unchanged across this group due to the short duration of this event (2 days). Sensitivity analyses show result is robust to parameter changes, being most sensitive to treatment costs of PONV and POD and cost of theatre time. The BI showed a cumulative saving of over £136 million if theatres in the UK adopt a phased increase in monitor use such that 1.35 million operations are conducted using monitors in five years time. http://tinyurl.com/YHEC-LinkedIn
